Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients - Platzbecker, Uwe; Nolte, Florian (Leukemia, 2014)
Gesehen am: 23.06.2016